The authors reply

New England Journal of Medicine

Volumn 377, Issue 8, 2017, Pages 787-788

  Sabatine, Marc S ^a   Giugliano, Robert P ^a   Pedersen, Terje R ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOCLONAL ANTIBODY;

CARDIOVASCULAR DISEASE; HUMAN;

ANTIBODIES, MONOCLONAL; CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; HUMANS;

EID: 85028473755     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1708587     Document Type: Letter

References (4)

1. LaRosa JC, Grundy SM, Waters DD, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005;352:1425-35.
2. Kidd SK, Bonaca MP, Braunwald E, et al. Universal classification system type of incident myocardial infarction in patients with stable atherosclerosis: observations from Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2°P)-TIMI 50. J Am Heart Assoc 2016;5(7): e003237.
3. Bonaca MP, Wiviott SD, Morrow DA, et al. Reduction in subtypes and sizes of myocardial infarction with ticagrelor in PEGASUS-TIMI 54 Circulation 2015 132:Su l 3:A11594 abstract
4. Ference BA, Robinson JG, Brook RD, et al. Variation in PCSK9 and HMGCR and risk of cardiovascular disease and diabetes. N Engl J Med 2016;375:2144-53.